TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Iperionx Limited ( (AU:IPX) ) has shared an update.
IperionX Limited has responded to a short seller report by Spruce Point Capital, emphasizing its commitment to confidentiality and data security, and highlighting its focus on scaling up titanium production in Virginia. The company has received significant support and validation from various U.S. Government programs, including a U.S. Army SBIR Phase III contract, reflecting the strategic importance of its technology for the U.S. titanium supply chain. IperionX is advancing its Virginia operations to significantly increase titanium production capacity, supported by U.S. Department of War funding, and is actively working on delivering high-performance titanium solutions for the U.S. military.
The most recent analyst rating on (AU:IPX) stock is a Buy with a A$9.25 price target. To see the full list of analyst forecasts on Iperionx Limited stock, see the AU:IPX Stock Forecast page.
More about Iperionx Limited
IperionX Limited operates in the titanium production industry, focusing on manufacturing and scaling up titanium products in Virginia. The company is involved in the development of a resilient, low-cost, and fully integrated U.S. mineral-to-metal titanium supply chain, with a market focus on defense and government contracts.
Average Trading Volume: 1,915,102
Technical Sentiment Signal: Buy
Current Market Cap: A$1.88B
For a thorough assessment of IPX stock, go to TipRanks’ Stock Analysis page.